# Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder

> **NCT03581643** · — · COMPLETED · sponsor: **Andreas Monsch** · enrollment: 430 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03581643
- **Lead sponsor:** Andreas Monsch
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-06
- **Primary completion:** 2018-05-08
- **Final completion:** 2018-05-08
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2018-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581643, "Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03581643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*